Hugo Cunha

Hugo Cunha has built a robust career in the pharmaceutical industry since 1993, with notable roles at major companies including Eli Lilly, Schering-Plough, and Lundbeck. They have extensive experience in both retail and hospital segments, participating in the launch of successful products such as Prozac and Lexapro. Since 2006, Hugo has focused on oncology, serving in various capacities including Senior Oncology Consultant at Adium and previously at Pfizer, where they concentrated on breast cancer treatments. They hold an MBA in Marketing from Fundação Getúlio Vargas and a degree in Business Administration from Centro Universitário Newton Paiva. Currently, Hugo is beginning a new role at Zodiac Oncologia, aiming to achieve impactful results in the field.